Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-24-002041
Filing Date
2024-12-23
Accepted
2024-12-23 16:30:33
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e6219_10-k.htm   iXBRL 10-K 1282045
2 EXHIBIT 19.1 e6219_ex19-1.htm EX-19.1 27450
3 EXHIBIT 21.1 e6219_ex21-1.htm EX-21.1 3864
4 EXHIBIT 23.1 e6219_ex23-1.htm EX-23.1 2656
5 EXHIBIT 31.1 e6219_ex31-1.htm EX-31.1 16197
6 EXHIBIT 31.2 e6219_ex31-2.htm EX-31.2 13930
7 EXHIBIT 32.1 e6219_ex32-1.htm EX-32.1 7064
13 GRAPHIC image_001.jpg GRAPHIC 292036
14 GRAPHIC image_002.jpg GRAPHIC 94445
  Complete submission text file 0001731122-24-002041.txt   5505180

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE avxl-20240930.xsd EX-101.SCH 32232
9 XBRL CALCULATION FILE avxl-20240930_cal.xml EX-101.CAL 29363
10 XBRL DEFINITION FILE avxl-20240930_def.xml EX-101.DEF 94830
11 XBRL LABEL FILE avxl-20240930_lab.xml EX-101.LAB 290122
12 XBRL PRESENTATION FILE avxl-20240930_pre.xml EX-101.PRE 223978
60 EXTRACTED XBRL INSTANCE DOCUMENT e6219_10-k_htm.xml XML 504661
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37606 | Film No.: 241574057
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)